Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Conference News TCT 2023

OCT, IVUS Both Seem to Be Good Options for Complex Coronary Lesions

Todd Neale

October 23, 2023

News Conference News TCT 2019

No Safety Signal Seen for CTO PCI at 3 Years: EUROCTO

Yael L. Maxwell

September 29, 2019

News Conference News TCT 2018

TALENT: Indian-Made Supraflex DES Stands Up Well Against Xience in All-Comers

Todd Neale

September 22, 2018

News Conference News TCT 2017

CrossBoss First Shows Promise for Antegrade CTO PCI

TCT Daily Staff

November 07, 2017

REVASCTO PCI Does Not Improve LV Function but Seems to Provide Symptom Relief

News Conference News TCT 2017

REVASC: CTO PCI Does Not Improve LV Function but Seems to Provide Symptom Relief

Todd Neale

October 31, 2017

News Conference News TCT 2016

Novel SES Fails to Match Xience EES for Chronic Total Occlusions

Yael L. Maxwell

November 08, 2016

News Conference News TCT 2016

Novel Method of Softening Hard CTO Plaque May Ease Procedural Difficulties

Yael L. Maxwell

November 02, 2016

Presentation TCT 2014

Delayed coverage of drug eluting stents after interventional revascularization of chronic total occlusions assessed by optical coherence tomography: the ALSTER-OCT-CTO registry

Presenter: Christian Heeger

September 16, 2014

Presentation TCT 2014

IVUS-CTO: A Prospective, Randomized Trial of Intravascular Ultrasound-Guided Versus Angiography-Guided Drug-Eluting Stent Intervention in Coronary Chronic Total Occlusions

Presenter: Gary S. Mintz, Ioannis Iakovou, Yang-Soo Jang

September 14, 2014

Presentation TCT 2013

Case Presentation 2: A Totally Occluded In-Stent CTO

Presenter: Lei Ge

October 31, 2013

Presentation TCT 2013

Two-year Clinical Outcomes Of Primary Stenting Of Totally Occluded Native Coronary Arteries III (PRISON III): A Randomized Comparison Of Sirolimus-Eluting Stent Implantation Wit...

Presenter: Koen Teeuwen, Ben Van den Branden, Jacques Koolen, Jose Henriques, Jan Tijssen, Hans Kelder, Ren? Van der Schaaf, Paul Vermeersch, Benno Rensing, Maarten j. Suttorp

January 31, 2013

Presentation TCT 2013

Short and Long Term Clinical Outcomes of Chronic Total Occlusion Treatment with a Latest Generation Drug Eluting Stent

Presenter: Alejandro Alcocer Chauvet, Ralf Blank, Attila Dirkali, Sagar Doshi, Andrejs Erglis, Paul Hsien-Li Kao, Chaim Lotan, Aleksandar NESKOVIC, Jawed Polad, Sergei Vlasenko

January 31, 2013

Presentation TCT 2012

TCT-75. Lumen Enlargement of the Coronary Segments Located Distal to Chronic Total Occlusions Successfully Treated with Drug-Eluting Stents at Follow-up

Presenter: Josep Gomez-Lara

October 23, 2012

Presentation TCT 2012

After CTO Recanalization, What Is the Role of Drug-Eluting Devices, Covered Stents, Etc?

Presenter: Thomas Zeller

October 23, 2012

Presentation TCT 2012

ACE-CTO: Angiographic Follow-up After Everolimus-eluting Stents in CTO

Presenter: Emmanouil Brilakis

October 22, 2012

Presentation TCT 2012

Three Year Outcomes Of Chronic Total Occlusion Treatment With Biolimus Eluting Biodegradable Polymer Stent Versus Sirolimus Eluting Permanent Polymer Stent In the LEADERS...

Presenter: Joanna J. Wykrzykowska, Patrick Serruys, Ton de Vries, Gerrit-Anne Van Es, Pawel Buszman, Axel Linke, Thomas Ischinger, Volker Klauss, Roberto Corti, Franz Eberli, William Wijns, Marie-Claude Morice, Robert Jan van Geuns, Peter Juni, Stephan Windecker, Carlo DiMario

January 03, 2012

Presentation TCT 2012

Relation Between Poststenting Peristent Plaque Components and Late Acquired Drug-Eluting Stent Malapposition: Virtual Histology-Intravascular Ultrasound Analysis

Presenter: Young Joon Hong, Myung Ho Jeong, Seung Uk Lee, Yun Ha Choi, Jin A Song, Dong Han Kim, Ki Hong Lee, Min Goo Lee, Keun Ho Park, Doo Sun Sim, Ju Han Kim, Youngkeun Ahn, Jeong Gwan Cho, Jung Chaee Kang

January 03, 2012

Presentation TCT 2012

Elective Stenting after Subintimal Tracking and Reentry (Star) Technique in Coronary Chronic Total Occlusions.

Presenter: Gabriella Visconti, Amelia Focaccio, Carlo Briguori

January 03, 2012

Presentation TCT 2012

Does Diabetes Mellitus Impact on Clinical Outcomes following Chronic Total Occlusion Intervention with Drug-eluting Stents?

Presenter: Amro Elnagar, Seung Woon Rha, Byoung Geol Choi, Sung Il Im, SunWon Kim, Jin Oh Na, Seong Woo Han, Cheol Ung Choi, Hong Euy Lim, Jin Won Kim, Eung Ju Kim, Chang Gyu Park, Hong Seog Seo, Dong Joo Oh

January 03, 2012

Advertisement

What’s Going to Be Hot at TCT 2025

OCT, IVUS Both Seem to Be Good Options for Complex Coronary Lesions

No Safety Signal Seen for CTO PCI at 3 Years: EUROCTO

TALENT: Indian-Made Supraflex DES Stands Up Well Against Xience in All-Comers

CrossBoss First Shows Promise for Antegrade CTO PCI

REVASC: CTO PCI Does Not Improve LV Function but Seems to Provide Symptom Relief

Novel SES Fails to Match Xience EES for Chronic Total Occlusions

Novel Method of Softening Hard CTO Plaque May Ease Procedural Difficulties

Delayed coverage of drug eluting stents after interventional revascularization of chronic total occlusions assessed by optical coherence tomography: the ALSTER-OCT-CTO registry

IVUS-CTO: A Prospective, Randomized Trial of Intravascular Ultrasound-Guided Versus Angiography-Guided Drug-Eluting Stent Intervention in Coronary Chronic Total Occlusions

Case Presentation 2: A Totally Occluded In-Stent CTO

Two-year Clinical Outcomes Of Primary Stenting Of Totally Occluded Native Coronary Arteries III (PRISON III): A Randomized Comparison Of Sirolimus-Eluting Stent Implantation Wit...

Short and Long Term Clinical Outcomes of Chronic Total Occlusion Treatment with a Latest Generation Drug Eluting Stent

TCT-75. Lumen Enlargement of the Coronary Segments Located Distal to Chronic Total Occlusions Successfully Treated with Drug-Eluting Stents at Follow-up

After CTO Recanalization, What Is the Role of Drug-Eluting Devices, Covered Stents, Etc?

ACE-CTO: Angiographic Follow-up After Everolimus-eluting Stents in CTO

Three Year Outcomes Of Chronic Total Occlusion Treatment With Biolimus Eluting Biodegradable Polymer Stent Versus Sirolimus Eluting Permanent Polymer Stent In the LEADERS...

Relation Between Poststenting Peristent Plaque Components and Late Acquired Drug-Eluting Stent Malapposition: Virtual Histology-Intravascular Ultrasound Analysis

Elective Stenting after Subintimal Tracking and Reentry (Star) Technique in Coronary Chronic Total Occlusions.

Does Diabetes Mellitus Impact on Clinical Outcomes following Chronic Total Occlusion Intervention with Drug-eluting Stents?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content